We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Urinary Test Diagnoses Cancer and Infertility-Causing Parasite

By LabMedica International staff writers
Posted on 03 Jun 2014
Print article
Image: A Finnigan Surveyor Plus High-Performance Liquid Chromatography (HPLC) instrument (Photo courtesy of Thermo Scientific).
Image: A Finnigan Surveyor Plus High-Performance Liquid Chromatography (HPLC) instrument (Photo courtesy of Thermo Scientific).
Image: Ova of Schistosoma haematobium in a urinary bladder specimen (Photo courtesy of Michael E. DeBakey).
Image: Ova of Schistosoma haematobium in a urinary bladder specimen (Photo courtesy of Michael E. DeBakey).
A fast, noninvasive way to test for a cancer-causing parasite that kills hundreds of thousands of people every year has been discovered.

About 243 million people are infected with schistosomiasis, which kills about 200,000 people every year and following infection, women often contract female genital schistosomiasis, which affects the cervix and uterus resulting in bleeding and pain during sex and infertility.

Scientists at the University of Porto (Portugal) collaborating with their colleagues in Angola, conducted a cross-sectional study of female residents of a region in Bengo province (Angola), endemic for schistosomiasis haematobia. Ninety-three women and girls, aged from two to 94 years were interviewed on present and previous urinary, urogenital and gynecological symptoms and complaints. Urine was collected from the participants for egg-based parasitological assessment of schistosomal infection, and biochemical analysis.

The entire micturition volume was filtered through a polycarbonate membrane (Whatman plc; Springfield Mill, UK) and subsequently the membrane was stained with Trypan blue. Schistosome ova retained on the membrane were identified with the aid of a light microscope. Liquid chromatography diode array detection electron spray ionization mass spectrometry (LC/UV-DAD/ESI-MSn) was performed on a Finnigan Surveyor Plus High-Performance Liquid Chromatography (HPLC) instrument (ThermoFinnigan; San Jose, CA, USA) equipped with a diode-array detector and a mass detector.

The investigators discovered catechols in the urine of women who tested positively for parasite eggs, but not in the urine of uninfected women. The team also found an association between catechols and infertility. In studying the mechanisms involved, the team found that the catechols downregulate estrogen receptors and trigger DNA mutations. Either or both of these actions could be responsible for the bladder cancer and infertility common to schistosomiasis patients.

Monica Catarina Botelho, PhD, the senior author of the study said, “Estrogen metabolism/degradation is a normal body process as estrogens are degraded into catechols and these into quinones. But if there are too many quinones, due to an excessive estrogen production or altered metabolism, this can cause DNA damage, because they tend to bind to DNA disturbing it. Now we detect these molecules not only in the serum, but also in the urine of patients infected with Schistosoma, while uninfected patients do not have them. They have been linked before to cancer as in thyroid, breast and prostate neoplasms, and autoimmunity. Now we see them in infertility associated with schistosomiasis infection.” The study was published on May 21, 2014, in the journal Public Library of Science ONE.

Related Links:

University of Porto
Whatman plc 
ThermoFinnigan


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Molecular Diagnostics

view channel
Image: Ultrasound-based duplex sonography combined with a new genetic testing procedure can identify clonal haematopoiesis (Photo courtesy of 123RF)

New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk

A key interest area in cardiovascular research today is the impact of clonal hematopoiesis on cardiovascular diseases. Clonal hematopoiesis results from mutations in hematopoietic stem cells and may lead... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.